(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: A Wingless β-Catenin Agonist That Increases Bone Formation Rate

被引:40
|
作者
Pelletier, Jeffrey C. [1 ]
Lundquist, Joseph T., IV [1 ]
Gilbert, Adam M. [4 ]
Alon, Nipa [4 ]
Bex, Frederick J. [2 ]
Bhat, Bheem M. [2 ]
Bursavich, Mattew G. [4 ]
Coleburn, Valerie E. [2 ]
Felix, Luciana A. [1 ]
Green, Daniel M. [1 ]
Green, Paula [2 ]
Hauze, Diane B. [1 ]
Kharode, Yogendra P. [2 ]
Lam, Ho-Sun [2 ]
Lockhead, Susan R. [3 ]
Magolda, Ronald L. [1 ]
Matteo, Jeanne J. [2 ]
Mehlmann, John F. [1 ]
Milligan, Colleen [2 ]
Murrills, Richard J. [2 ]
Pirrello, Jennifer [2 ]
Selim, Sally [2 ]
Sharp, Michael C. [2 ]
Unwalla, Ray J. [1 ]
Vera, Matthew D. [1 ]
Wrobel, Jay E. [1 ]
Yaworsky, Paul [2 ]
Bodine, Peter V. N. [2 ]
机构
[1] Wyeth Res, Chem Sci, Collegeville, PA 19426 USA
[2] Wyeth Res, Tissue Repair, Collegeville, PA 19426 USA
[3] Wyeth Res, Drug Safety & Metab, Collegeville, PA 19426 USA
[4] Wyeth Res, Chem Sci, Pearl River, NY 10965 USA
关键词
WNT; MUTATION; PATHWAY; OSTEOPOROSIS; INHIBITORS; PROTEINS;
D O I
10.1021/jm9014197
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A high-throughput screening campaign to discover small molecule leads for the treatment of bone disorders concluded with the discovery of a compound with a 2-aminopyrimidine template that targeted the Wnt beta-catenin cellular messaging system. Hit-to-lead in vitro optimization for target activity and molecular properties led to the discovery of (1-(4-(naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine (5, WAY-262611). Compound 5 has excellent pharmacokinetic properties and showed a dose dependent increase in the trabecular bone formation rate in ovariectomized rats following oral administration.
引用
收藏
页码:6962 / 6965
页数:4
相关论文
共 50 条
  • [11] Crystal Structure and Theoretical Energy Gap of 2-(2-((4-(Pyridin-2-yl)pyrimidin-2-yl)disulfanyl)pyrimidin-4-yl) pyridinium Hexafluorophosphate
    陶涛
    赵煚珖
    曹晖
    结构化学, 2017, 36 (02) : 229 - 235
  • [12] Crystal structure of 4-{[(naphthalen-2-yl)sulfonylamino]methyl} cyclohexanecarboxylic acid
    Danish, Muhammad
    Tahir, Muhammad Nawaz
    Hussain, Asif
    Ashfaq, Muhammad
    Sadiq, Muhammad Nadeem
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2015, 71 : O145 - +
  • [13] Synthesis of symmetrical di(pyrimidin-2-yl)-1,2,4-triazoles and di(pyrimidin-2-yl)-1,2,4,5-tetrazines
    V. P. Krivopalov
    M. B. Bushuev
    Yu. V. Gatilov
    O. P. Shkurko
    Russian Chemical Bulletin, 2010, 59 : 1808 - 1816
  • [14] N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
    Korlyukov, Alexander A.
    Dorovatovskii, Pavel V.
    Vologzhanina, Anna V.
    MOLBANK, 2022, 2022 (04)
  • [15] Synthesis of symmetrical di(pyrimidin-2-yl)-1,2,4-triazoles and di(pyrimidin-2-yl)-1,2,4,5-tetrazines
    Krivopalov, V. P.
    Bushuev, M. B.
    Gatilov, Yu. V.
    Shkurko, O. P.
    RUSSIAN CHEMICAL BULLETIN, 2010, 59 (09) : 1808 - 1816
  • [16] [(E)-1-(Naphthalen-2-yl)ethylidene]-(naphthalen-1-ylmethyl)amine
    Bruno, Sofia M.
    Fernandes, Jose A.
    Goncalves, Isabel S.
    Paz, Filipe A. Almeida
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3143 - +
  • [17] Synthesis and molecular structure of 1-(pyrimidin-2-yl)-2-(4-aryl-1,3-thiazol-2-yl)hydrazines
    Erkin, A. V.
    Krutikov, V. I.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2011, 81 (08) : 1699 - 1704
  • [18] Synthesis and molecular structure of 1-(pyrimidin-2-yl)-2-(4-aryl-1,3-thiazol-2-yl)hydrazines
    A. V. Erkin
    V. I. Krutikov
    Russian Journal of General Chemistry, 2011, 81 : 1699 - 1704
  • [19] {Bis[4-(2-pyridyl)pyrimidin-2-yl]sulfane}dichloridocobalt(II)
    Zhu, Hai-Bin
    Li, Lei
    Ji, Jun-Feng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : M784 - U888
  • [20] {Bis[4-(2-pyridyl)pyrimidin-2-yl] sulfide}-dibromidocobalt(II)
    Li, Cai-Yun
    Tong, Xiao-Lan
    Hu, Tong-Liang
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : M856 - U77